CXL sem limites
Descubra o futuro da do crosslinking
Para CXL moderno: serve em lâmpadas de fenda Haag Streit e Zeiss.
Montagem de mesaFor classic CXL: table mount accessory available.
Protocolos IntegradosEscolha entre diversos protocolos clínicos predefinidos.
Faixa de intensidadesFornece 3, 9, 15, 18 e 30 mW/cm².
Luz pulsada e contínua
For various keratoconus
Para diversas configurações de ceratocone e ceratites infecciosas.
Perfil ajustado à espessura
Beam profile delivers
O perfil do feixe fornece mais energia à periferia corneal.
Bateria de última geração
Projetado para durar milhares de tratamentos.
Acessível a cadeiras de rodas
Trate pessoas em cadeiras de rodas com comodidade
The C-eye device is CE marked for the following indications: keratoconus, ectasia after LASIK/PRK, pellucid marginal degeneration, infectious keratitis, sterile corneal melting, bullous keratopathy. The C-eye is not available for sale in the United States.
O dispositivo C-eye da EMAGine traz a tecnologia de CXL à lâmpada de fenda. Simples, eficiente e seguro, para iniciantes à usuários experientes.
Realize CXL na lâmpada de fenda. Ou use o dispositivo C-eye como qualquer outro dispositivo de CXL: com um suporte de mesa em seu centro cirúrgico.
Você trabalha em vários locais? Leve o C-eye onde quer que vá. Carregue-o via USB-C, com o carregador do seu smartphone ou laptop.
Reduz o tempo e os custos relacionados à realização de CXL
O dispositivo C-eye revolucionará o procedimento de Crosslinking
Somos 221 mil oftalmologistas unidos por um só equipamento: a lâmpada de fenda. É o que define a nossa profissão. A tecnologia C-eye proporciona a todos os oftalmologistas a capacidade de executar CXL na própria lâmpada de fenda. Tudo fora de um centro cirúrgico. Simples Eficiente Seguro
Posso realizar o CXL em meu escritório?
Remember that every cross-linking procedure not only improves biomechanics, it also “disinfects” the cornea by directly killing all micro-organisms and by inhibiting cellular replication. This is why a cornea at the end of every CXL and PACK-CXL procedure is “sterile”. And by the way: office-based cataract surgery e office-based intravitreal injections have been performed in many thousands of cases without increased infection risk.
Irradiation time is not too long. Current modern protocols are integrated in the C-eye device and treat in as little as 10 minutes (CXL) and 4 minutes (PACK-CXL). See the published approach aqui.
We need 3 elements for successful cross-linking: UV light, oxygen and riboflavin. Both UV light and oxygen do not “care” whether the patient is laying down or sitting. As for riboflavin, published research shows that riboflavin concentration is stable in the upright position for up to 60 minutes - much longer than we need for a CXL treatment.
Offer the patient the comfortable surgeon’s chair with the armrest and take the extra time to ensure that the patient is well-adjusted. Then, the patient is very comfortable.
Fixation is no issue. Offer the patient the fixation target that most slit lamps offer (for retinal examination) and the patient will keep a very steady fixation, as you can see aqui.
Find more answers in our FAQ section.


O dispositivo C-eye se encaixa em diversos modelos de lâmpadas de fenda Haag-Streit e Zeiss.

POSTS
High fluence PACK-CXL is better than low fluence PACK-CXL
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment
CXL and Oxygen: Explaining the Relationship
EMAGine’s Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions.
Digital Ophthalmology Interviews EMAGine CEO, Nikki Hafezi
Dr. Sebastian Siebelman from the media outlet, “Digital Ophthalmology” interviewed EMAGine AG’s Chief Executive Officer, Nikki Hafezi, on how she turns ideas into reality – and this includes EMAGine AG!
Landmark PACK-CXL trial published
This month, a landmark PACK-CXL trial was published that shows that PACK-CXL is an effective corneal infection therapy.
PACK-CXL as adjuvant therapy improves outcomes
“PACK-CXL is safe for use in bacterial keratitis cases. It also seems to add value in reducing healing time and improving final visual acuity while reducing the need for tectonic keratoplasty” noted the study authors.
What’s the best way to cross-link the eyes of wheelchair users?
It can be challenging to cross-link the eyes of wheelchair users – for the patient and clinic staff alike. One
What is the future of CXL?
Corneal cross-linking (CXL) has been used in the clinic for over 20 years now, but if you ever wanted to
More posts:
VÍDEOS
Webinars and congresses
Upcoming Event
Janeiro 21, 2022
NUHS 36th Anniversary Conference

Location: Singapore
Language: English
Upcoming Event
Janeiro 15, 2022
Muscat International Ophthalmology Conference (MIOC)

Location: Muscat, Oman
Language: English
Upcoming Event
Dezembro 4, 2021
Kölner Adventssymposium 2021

Location: Köln, Germany
Language: German
Upcoming Event
Novembro 25, 2021
Middle East Africa Council of Ophthalmology

Location: Dubai, UAE
Language: English
Upcoming Event
Novembro 18, 2021
14th World Down Syndrome Congress

Location: Dubai, UAE
Language: English
Upcoming Event
Novembro 11, 2021
La Société Marocaine de la chirurgie réfractive

Location: Rabat, Morocco
Language: French
Upcoming Event
Novembro 4, 2021
Sorocaba Eye Bank

Location: Brasil
Language: English
Upcoming Event
Outubro 28, 2021
Emirates Society Of Ophthalmology

Location: Dubai, UAE
Language: English
Upcoming Event
Outubro 23, 2021
LV Prasad Eye Institute

Location: Hyderabad, India
Language: English
Upcoming Event
Outubro 23, 2021
65th Brazilian Congress of Ophthalmology

Location: Natal, Brazil
Language: English